Clinical Performance Evaluation of the NeuMoDx™ EBV Quant Assay 2.0 in Immunocompromised Transplant Patients
Clinical trial NCT06681025 · COMPLETED
Trial details
- NCT number
- NCT06681025
- Sponsor
- QIAGEN Gaithersburg, Inc
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-08-31
- Primary completion
- 2023-12-31
- Enrollment
- 1070
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.